Hosted on MSN9h
EU reshapes HTAs: is the industry ready for it?
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Medscape10h
EMA Launches Review of Finasteride for Suicidal Ideation
The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...
European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...
Euro Weekly News4d
Flu season crisis: Polands seeks European aid
Flu season has hit Poland hard, straining the country’s healthcare system. In response, Health Minister Izabela Leszczyna has ...
Arcturus Therapeutics and CSL’s Kostaive COVID-19 vaccine approved in Europe
CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...
Maternal acetaminophen (paracetamol) use may alter placental gene expression, raising ADHD risk in children
Maternal acetaminophen exposure during pregnancy is associated with a higher likelihood of childhood attention deficit ...
FierceBiotech1d
Galapagos drops one CD19 CAR-T to focus on 'flagship' program
Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s seemingly never-ending mission to recalibrate ...
CSL, Arcturus Therapeutics announce European Commission approval for Kostaive
CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...
centerforbiosimilars13h
The Top 5 Biosimilar Articles for the Week of February 10
Enzeevu (aflibercept-abzv), a biosimilar developed by Sandoz, demonstrated biosimilarity to reference aflibercept (Eylea) in ...